A day after the Subject Expert Committee (SEC) meeting discussed the Kiran Majumdar Shaw-led Biocon Biologics Limited (BBL)’s Insulin Aspart injection, an executive of her company asked middlewoman Guljit Sethi to modify the recommendations of the committee, the Central Bureau of Investigation (CBI) said. Agency sources told The New Indian that while investigating the alleged bribery case, […]